Clinical trial

Effective Dose of Remiazolam Tosylate Combined With Propofol in Upper Gastrointestinal Endoscopy Sedation: a Dose-determination Study Using Dixon's Up-and-down Method

Name
HR7056+propofol
Description
This study used sequential method(Dixon's up and douwn) to determine the effective dose of remiazolam combined with propofol in painless upper gastrointestinal endoscopy
Trial arms
Trial start
2023-06-01
Estimated PCD
2023-06-12
Trial end
2023-06-30
Status
Completed
Treatment
Remimazolam tosilate
The fixed dose of propofol in this study was 0.5mg/kg, with an injection time of 30 seconds. Subsequently, remimazolam was administered at an initial dose of 0.1mg/kg. After 1 minute of administration, sedation was evaluated using MOAA/S. When the MOAA/S score was ≤ 1, endoscopic examination could begin. If the patient did not show physical activity or coughing, sedation was considered successful, and the next patient's medication dose was reduced by 0.02mg/kg; On the contrary, if sedation fails, the next patient will receive an additional 0.02mg/kg of medication.Successful sedation results in a positive reaction, while failure results in a negative reaction. This study ends when 7 positive and negative reactions intersect
Arms:
remimazolam tosylate
Size
22
Primary endpoint
Incidence of body movements or coughing
Day 1
Eligibility criteria
Inclusion Criteria: * ASA grading I to II, with a BMI of 18 to 30 kg/m2 Exclusion Criteria: * Uncontrolled severe hypertension, previous history of abnormal anesthesia, unstable angina and myocardial infarction, abnormal liver and kidney function, acute upper respiratory tract infection, suspected difficulty in the airways, allergies to opioids, milk, eggs, and propofol, long-term use of sedative and analgesic drugs.
Protocol
{'studyType': 'INTERVENTIONAL', 'phases': ['NA'], 'designInfo': {'allocation': 'NA', 'interventionModel': 'SEQUENTIAL', 'interventionModelDescription': "We will use the Dixon's up and down method.", 'primaryPurpose': 'TREATMENT', 'maskingInfo': {'masking': 'NONE'}}, 'enrollmentInfo': {'count': 22, 'type': 'ACTUAL'}}
Updated at
2023-08-01

1 organization